Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

SpringWorks Therapeutics, Inc. (SWTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 Lin Tai-An (Chief Scientific Officer) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Granted 24,000 shares @ $0
Granted 75,000 options to buy @ $22.8, valued at $1.7M
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2023 4 Cassidy James (Chief Medical Officer) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Granted 5,720 shares @ $0
07/05/2023 4 Smith L. Mary (Chief Development Officer) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Granted 5,720 shares @ $0
05/25/2023 4 Schwartz Jeffrey Lawrence (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Granted 4,648 shares @ $0
Granted 13,774 options to buy @ $32.27, valued at $444.5k
05/25/2023 4 LYNCH DANIEL (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Granted 4,648 shares @ $0
Granted 13,774 options to buy @ $32.27, valued at $444.5k
05/25/2023 4 Lewis-Hall Freda C (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Granted 4,648 shares @ $0
Granted 13,774 options to buy @ $32.27, valued at $444.5k
05/25/2023 4 Hambleton Julie (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Granted 4,648 shares @ $0
Granted 13,774 options to buy @ $32.27, valued at $444.5k
05/25/2023 4 Fuhrman Alan (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Granted 4,648 shares @ $0
Granted 13,774 options to buy @ $32.27, valued at $444.5k
04/05/2023 4 Ashar Bhavesh (Chief Commercial Officer) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,375 shares @ $25.25, valued at $34.7k
03/20/2023 4 Schwartz Jeffrey Lawrence (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Sold 1,750,000 shares @ $28.5, valued at $49.9M
03/16/2023 4 Hambleton Julie (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Sold 1,106 shares @ $31.5021, valued at $34.8k
01/27/2023 4 Pichl Daniel (Chief People Officer) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Sold 858 shares @ $31, valued at $26.6k
01/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/09/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/09/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/09/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/09/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/09/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/09/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/09/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/09/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/09/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2022 4 Ashar Bhavesh (Chief Commercial Officer) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,464 shares @ $56.9, valued at $83.3k
Granted 100,000 options to buy @ $26.98, valued at $2.7M
10/11/2022 3 Cassidy James (Chief Medical Officer) has filed a Form 3 on SpringWorks Therapeutics, Inc.
09/14/2022 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Sold 123,897 shares @ $31.96, valued at $4M
Sold 30,000 shares @ $31.98, valued at $959.4k
08/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy